Announcements Trials
Browse Landscape

Phase

Phase 2 29Phase 3 6Phase NA 5Phase 4 5Phase EARLY_PHASE1 4Phase 1/2 3Phase 2/3 2Phase 1 2

Status

Recruiting 3Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 3Lymphoid 2Breast 2Other hematologic neoplasm 1Myeloid 1Gynecologic 1

Conditions

Prostatic Neoplasms 3Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neurologic Manifestations 1Myelodysplastic Syndromes 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Graft vs Host Disease 1Carcinoma, Renal Cell 1COVID-19 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Atorvastatin × Clear all
NCT03819101 2026-05-06

PEACE-4

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
1,210 enrolled
Genitourinary

Prostatic Neoplasms

NCT05796973 2025-06-27

MOVES

Tampere University Hospital

Phase 3 Recruiting
240 enrolled
BreastGenitourinaryGynecologic

Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT04904536 2025-04-10

STRONGER

The George Institute

Phase 3 Active not recruiting
190 enrolled
Lymphoid

COVID-19, Lymphoma, Follicular, Neurologic Manifestations

NCT04026230 2022-10-21

ESTO2

Tampere University Hospital

Phase 3 Unknown
400 enrolled
Genitourinary

Prostatic Neoplasms

NCT03066466 2021-04-27

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Loyola University

Phase 3 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04601116 2021-01-14

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Aarhus University Hospital

Phase 3 Recruiting
3,360 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡